
Browsing restrictions can be lifted for a fee.
Sinon Corporation manufactures and sells various chemicals and fertilizers. The company offers crop protection products, such as agrochemicals, fertilizers, farming materials, seeds, and seedlings, etc. It also provides product design, mold design and manufacturing, blow molding, injection molding, PET injection molding, PET extrusion blow molding, one-step injection blow molding, printing, gilding, labeling, shrink sleeving, etc. In addition, the company engages in the orchid business; houseware, catering services, and retail of agricultural products; import and export of medical and chemical products; designs and sale of software; software designing and information security maintenance; and retail sale of tobacco and alcoholic drinks, as well as supermarket. Further, it manufactures and sells cement, and offers pharmaceuticals. The company was formerly known as Shinung Chemical Industry Co., Ltd. and changed its name to Sinon Corporation in 1979. Sinon Corporation was founded in 1955 and is based in Taichung, Taiwan.
1712
興農
0.64%
(0.01)
The most recent financial report for 興農 (1712) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 1712's short-term business performance and financial health. For the latest updates on 1712's earnings releases, visit this page regularly.
According to historical valuation range analysis, 興農 (1712)'s current price-to-earnings (P/E) ratio is 14.5, placing it in the Overvalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning optimistic. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.
According to the latest financial report, 興農 (1712) reported an Operating Profit of 257.52M with an Operating Margin of 5.88% this period, representing a decline of 8.4% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
In the latest financial report, 興農 (1712) announced revenue of 4.38B, with a Year-Over-Year growth rate of 0.4%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
At the end of the period, 興農 (1712) held Total Cash and Cash Equivalents of 1.99B, accounting for 0.13 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
In the latest report, 興農 (1712) achieved the “three margins increasing” benchmark, with a gross margin of 29.22%%, operating margin of 5.88%%, and net margin of 5.12%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 1712's profit trajectory and future growth potential.
According to the past four quarterly reports, 興農 (1712)'s earnings per share (EPS) shows a declining trend, with the latest EPS at 0.53. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
興農 (1712)'s Free Cash Flow (FCF) for the period is 116.09M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 156.82% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.